Tyra Biosciences, Inc. logo TYRA - Tyra Biosciences, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 7
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $50.50 DETAILS
HIGH: $59.00
LOW: $42.00
MEDIAN: $51.50
CONSENSUS: $50.50
UPSIDE: 55.53%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 14.67
Quick Ratio 14.67
Solvency Ratio -5.096
Cash Ratio 4.28

Valuation Ratios

Ratio Value
Price/Earnings
-13.06
Peers avg: 16.1
PEG Ratio -0.39
Forward PEG -0.39
Price/Book 6.05
Price/Sales 0.00
Price/FCF -16.45
Price/Op Cash Flow -16.47

Debt Ratios

Ratio Value
Debt/Assets 0.0206
Debt/Equity 0.0224
Debt/Capital 0.0219
Long-Term Debt/Capital 0.0202
Financial Leverage 1.09

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -5.258
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 100.1%

Coverage Ratios

Ratio Value
Debt Service Coverage -280.12
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage -201.57
Operating Cash Flow Coverage -16.38
Capital Expenditure Coverage -674.77
Dividend + Capital Expenditure Coverage -674.77

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -2.012
Debt/Share 0.0975
Cash/Share 4.30
Book Value/Share 4.35
Tangible BV/Share 4.35
Equity/Share 4.35
Operating Cash Flow/Share -1.596
Capital Expenditure/Share 0.002
FCF/Share -1.599

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.903
Price/Fair Value 6.05
Debt/Market Cap 0.0037
Effective Tax Rate 0.0%
Enterprise Value Multiple -11.31